- $2.71bn
- $3.09bn
- $1.07bn
- 76
- 47
- 81
- 78
Annual balance sheet for Synaptics, fiscal year end - June 28th, USD millions except per share, conversion factor applied.
2021 June 30th | 2022 June 25th | 2023 June 24th | 2024 June 29th | 2025 June 28th | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 836 | 876 | 934 | 877 | 453 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 228 | 323 | 165 | 144 | 130 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Current Assets | 1,180 | 1,403 | 1,272 | 1,162 | 752 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 123 | 124 | 115 | 122 | 117 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Other Long Term Assets | |||||
| Total Assets | 2,227 | 2,858 | 2,611 | 2,825 | 2,584 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 787 | 463 | 260 | 277 | 271 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 1,260 | 1,592 | 1,368 | 1,358 | 1,190 |
| Non Redeemable Preferred Stock | |||||
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Other Equity | |||||
| Total Equity | 967 | 1,266 | 1,243 | 1,467 | 1,395 |
| Total Liabilities & Shareholders' Equity | 2,227 | 2,858 | 2,611 | 2,825 | 2,584 |
| Total Common Shares Outstanding |